Monoclonal antibodies crucial to fighting emerging infectious diseases, say NIH officials
Monoclonal antibodies have shown promise in the fight against cancer and autoimmune diseases. They also may play a critical role in future battles against emerging infectious disease outbreaks, according to a new article by scientists from the NIAID. The article is published in the NEJM. March 08, 2018